ClinicalTrials.Veeva

Menu

Online Adaptive Radiation Therapy for Rectal Cancer

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status and phase

Not yet enrolling
Phase 2
Phase 1

Conditions

Rectal Cancer

Treatments

Radiation: Online adaptive radiation therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05911789
ART-rectal cancer

Details and patient eligibility

About

In the present study, the investigators will evaluate the efficacy, toxicities, and of online adaptive radiation therapy (ART) for patients with rectal cancer treated with neoadjuvant chemoradiotherapy.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. ≥18 years old;
  2. Diagnose with rectal cancer;
  3. T3-T4 or N+, and no distant metastasis
  4. Neoadjuvant chemoradiotherapy intended;
  5. Surgery is expected after neoadjuvant therapy;
  6. ECOG score 0-2, expected to lie in the treatment bed for at least half an hour;

Exclusion criteria

  1. With contraindications to rectal MRI;
  2. Received surgery, radiotherapy or chemotherapy for rectal cancer;
  3. History of pelvic radiotherapy.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Online adaptive radiation therapy
Experimental group
Description:
Patients receive adaptive radiotherapy therapy and concurrent chemotherapy.
Treatment:
Radiation: Online adaptive radiation therapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems